Financial Gain: Just One of Many Motives

It's hard to concoct a research scenario in which the investigator does not desire one result over another. Perhaps a bit of government-supported contract research falls into this category--the engineer paid by the Air Force, let's say, to measure the tensile strength of several compounds or the biochemist paid by the Food and Drug Administration to assess the bioactivity of two generic agents. But most investigators do care about the results; that's why they do the research in the first place

Written byWalter Brown
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

But most investigators do care about the results; that's why they do the research in the first place. And that's why, on a regular, sometimes daily, basis your everyday working scientist comes up against the conflict between her desire to achieve a certain result and her obligation to uncover the truth. That conflict is an important part of the scientist's inner world. It influences every feature of the research endeavor from the research question selected to research design, methods of measurement, and the statistics applied in data analysis.

An array of motives far too vast to enumerate lie beneath the desire to find one "truth" rather than another. Among the most powerful and ungovernable stands desire for recognition. But less troublesome ones are also at play. A "positive" result can bring a grant, the gratitude of your supervisor, a poster at the Federation meeting and with it another crack at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies